₹424.68 Crores | Listing at BSE, NSE | Wed, Mar 11, 2026 - Wed, Mar 25, 2026
Healthcare Global Enterprises Limited Rights Issue comprises 0.8295 Cr equity shares aggregating to ₹424.68 Cr, offered at an issue price of ₹512 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Mar 2, 2026, with the Rights Issue being offered in the entitlement ratio of 1 : 17.
The term of payment is defined as following : On Application
The Rights Entitlements are expected to be credited to eligible demat accounts on Mar 27, 2026.
The Rights Issue opens on Mar 11, 2026, and closes on Mar 25, 2026, with renunciation of Rights Entitlements permitted up to Mar 20, 2026.
The deemed date of allotment is Mar 27, 2026, following which the equity shares are expected to be credited to demat accounts on Mar 30, 2026 and listed at the NSE and the BSE on Apr 1, 2026.
Kfin Technologies Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Healthcare Global Enterprises Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Mon, Mar 2, 2026
Entitlement Ratio
1 : 17
Open Date
Wed, Mar 11, 2026
Close Date
Wed, Mar 25, 2026
On Application
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Total Income | 2,222.85 | 1,912.12 |
| Profit After Tax | 48.83 | 41.32 |
| NET Worth | 922.45 | 825.78 |
| Reserves and Surplus | 783.03 | 686.49 |
| Amount in ₹ Crore | ||
Healthcare Global Enterprises Limited is a leading chain of oncology and specialty hospitals in India, focusing on comprehensive cancer care services. It operates integrated outpatient, diagnostic and treatment facilities.
The company emphasizes cutting-edge technology, multidisciplinary care, and research-driven treatment protocols to improve patient outcomes. It serves a large patient base with specialized medical expertise.
Healthcare Global Enterprises Limited partners with international oncology experts, invests in infrastructure, and strives to expand access to quality cancer care across regions. It aims for sustainable growth and enhanced healthcare delivery.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Pre-payment and/ or repayment of all, or a portion of, certain outstanding borrowings availed by the Company and by one of the wholly owned Subsidiaries, HCG NCHRI Oncology LLP | 170.00 |
| 2 | Part-payment of consideration for acquisition of 34.00% additional stake in equity share capital of Vizag Hospital and Cancer Research Center Private Limited, one of the existing Subsidiaries | 154.04 |
| 3 | General corporate purposes | 95.57 |
| Total | 419.61 |
[Dilip Davda] HGEL is engaged in providing specialty healthcare in India with focus on cancer, fertility, and other tertiary care. The company marked growth in its top lines for the reported periods, but 9M-FY26 hints at pressure on margins. It is operating in a highly competitive and fragmented segment. Based on its recent financial data and market trades, the RI appears aggressively priced. Well-informed investors may park moderate funds for long term. Read detail review...
HealthCare Global Enterprises Rights Issue 2026 got oversubscribed by 1.29 times by the end of the bidding period with total bid quantity received by BSE and NSE of 1,07,13,709 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | NSE Bid Quantity | Total Bid Quantity | Subscription Times |
|---|---|---|---|---|
Mar 25 2026 17:00:00 | 29,24,107 | 77,89,602 | 1,07,13,709 | 1.29x |
Healthcare Global Enterprises Limited
HCG Tower, No. 8,
P Kalinga Rao Road,
Sampangi Rama Nagar,
Bangalore Metropolitan Region, 560027
The HealthCare Global Enterprises Rights Issue 2026 opens on Wed, Mar 11, 2026, and closes on Wed, Mar 25, 2026.
HealthCare Global Enterprises Rights Issue 2026 Schedule
| Last Date for credit of Rights Entitlements | Wed, Mar 4, 2026 |
| Last Date for renunciation of Rights Entitlements | Fri, Mar 20, 2026 |
| Issue Opening Date | Wed, Mar 11, 2026 |
| Issue Closing Date | Wed, Mar 25, 2026 |
| Date of Allotment (on or about) | Fri, Mar 27, 2026 |
| Date of Credit (on or about) | Mon, Mar 30, 2026 |
| Date of Listing (on or about) | Wed, Apr 1, 2026 |
You can apply for HealthCare Global Enterprises Rights Issue 2026 in two ways:
Steps to apply for HealthCare Global Enterprises Rights Issue 2026 using Net Banking (ASBA)
Steps to apply for HealthCare Global Enterprises Rights Issue 2026 using Registrar's website (R-WAP)
